Cardiovascular Complications and COVID-19 (CovCardioVasc-Study) (CovCardioVasc)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04335162 |
Recruitment Status : Unknown
Verified April 2020 by Centre Hospitalier Universitaire de Nice.
Recruitment status was: Recruiting
First Posted : April 6, 2020
Last Update Posted : November 24, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
COVID Acute Coronary Syndrome Myocardial Infarction Myocarditis Venous Thromboembolism Deep Vein Thrombosis Pulmonary Embolism |
Study Type : | Observational |
Estimated Enrollment : | 100 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Cardiovascular Complications in Patients With COVID-19 |
Actual Study Start Date : | February 28, 2020 |
Estimated Primary Completion Date : | August 31, 2021 |
Estimated Study Completion Date : | August 31, 2021 |

Group/Cohort |
---|
Patients with cardiovascular complications
Patients presenting with cardiomyopathies or venous thromboembolism
|
Patients without cardiovascular complications
Patients without cardiomyopathies or venous thromboembolism
|
Intensive Care Unit patients
Patients admitted in intensive care unit
|
Hospital Ward patients
Patients admitted in hospital ward
|
- Determine the incidence of cardiomyopathies and venous thromboembolism [ Time Frame: 28 days ]Incidence of cardiomyopathies and/or venous thromboembolism at day 28
- Mortality [ Time Frame: 28 days ]Incidence of mortality at day 28
- Duration of mechanical ventilation [ Time Frame: hospitalisation duration ]Number of day of using mechanical ventilation for each patients
- Shock [ Time Frame: hospitalisation duration ]Incidence of shock during hospitalisation
- length of stay [ Time Frame: hospitalisation duration ]Number of day at hospital
- Mechanical ventilation [ Time Frame: hospitalisation duration ]Setting up or not of mechanical ventilation
- Renal replacement therapy [ Time Frame: hospitalisation duration ]Administration or not of renal replacement therapy
Biospecimen Retention: Samples Without DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- All consecutive patients with COVID-19 infection admitted to the ICU or hospitalized because of severe form (eg: hypoxia, orthopnea, pneumonitis, kidney insufficiency) will be included
Exclusion Criteria:
- Patients under 18 years

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04335162
Contact: Denis DOYEN | 0033492035510 | doyen.d@chu-nice.fr |
France | |
Centre Hospitalier de Cannes | Recruiting |
Cannes, France, 06400 | |
Contact: Pierre-Marie BERTRAND PM.BERTRAND@ch-cannes.fr | |
Contact: Alexandre ROBERT A.ROBERT@ch-cannes.fr | |
CHU de Dijon | Recruiting |
Dijon, France | |
Contact: Belaid BOUHEMAD belaid_bouhemad@hotmail.com | |
Centre Hospitalier de Draguignan | Recruiting |
Draguignan, France, 83300 | |
Contact: Andres Jurado andres.jurado@wanadoo.fr | |
Centre Hospitalier de Grasse | Recruiting |
Grasse, France, 06130 | |
Contact: Pierre-Marie Bertrand pm.bertrand@ch-cannes.fr | |
Contact: Alexandre Robert a.robert@ch-cannes.fr | |
Clinique Ambroise-Paré | Recruiting |
Neuilly, France | |
Contact: Lee NGUYEN nguyen.lee@icloud.com | |
CHU de Nice | Recruiting |
Nice, France, 06200 | |
Contact: Denis DOYEN 0033492035510, doyen.d@chu-nice.fr | |
Hôpitaux Universitaires Paris Centre - Hôpital Cochin | Recruiting |
Paris, France, 75014 | |
Contact: Mathieu Jozwiak 0033158412661 mathieu.jozwiak@aphp.fr | |
Sub-Investigator: Jonathan MAREY | |
CHU de REIMS | Recruiting |
Reims, France | |
Contact: Vincent DUPONT vdupont@chu-reims.fr |
Principal Investigator: | Denis DOYEN | CHU de NICE - Archet 1 |
Responsible Party: | Centre Hospitalier Universitaire de Nice |
ClinicalTrials.gov Identifier: | NCT04335162 |
Other Study ID Numbers: |
20reamedcovid01 |
First Posted: | April 6, 2020 Key Record Dates |
Last Update Posted: | November 24, 2020 |
Last Verified: | April 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | no data sharing plan has been established. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Pulmonary Embolism Myocardial Infarction Thrombosis Acute Coronary Syndrome Embolism Thromboembolism Venous Thromboembolism Venous Thrombosis Myocarditis Infarction Ischemia |
Pathologic Processes Necrosis Myocardial Ischemia Heart Diseases Cardiovascular Diseases Vascular Diseases Embolism and Thrombosis Lung Diseases Respiratory Tract Diseases Cardiomyopathies |